Search Results - "Mohanakumar, Kochupurackal P"

Refine Results
  1. 1

    Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson’s Disease by Dutta, Debashis, Ali, Nilufar, Banerjee, Emili, Singh, Raghavendra, Naskar, Amit, Paidi, Ramesh Kumar, Mohanakumar, Kochupurackal P

    Published in Molecular neurobiology (01-01-2018)
    “…Since substantia nigra (SN) and ventral tegmental area (VTA) dopaminergic neurons are, respectively, susceptible or largely unaffected in Parkinson’s disease…”
    Get full text
    Journal Article
  2. 2

    Quercetin Improves Behavioral Deficiencies, Restores Astrocytes and Microglia, and Reduces Serotonin Metabolism in 3‐Nitropropionic Acid‐Induced Rat Model of Huntington's Disease by Chakraborty, Joy, Singh, Raghavendra, Dutta, Debashis, Naskar, Amit, Rajamma, Usha, Mohanakumar, Kochupurackal P.

    Published in CNS neuroscience & therapeutics (01-01-2014)
    “…Summary Aim Huntington's disease (HD) is an autosomal dominant disorder, for which clinically available drugs offer only symptomatic relief. These prescription…”
    Get full text
    Journal Article
  3. 3

    Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents by Borah, Anupom, Mohanakumar, Kochupurackal P.

    Published in Journal of pineal research (01-11-2009)
    “…:  We tested the hypothesis that melatonin regulates formation of 6‐hydroxydopamine (6‐OHDA) in the brain and thereby protects animals from dopaminergic…”
    Get full text
    Journal Article
  4. 4

    Quality of life and concerns of parkinson's disease patients and their caregivers during COVID-19 pandemic: An indian study by Banerjee, Sourav, Mukherjee, Adreesh, Bhattacharyya, Bidisha, Mohanakumar, Kochupurackal, Biswas, Atanu

    Published in Annals of the Indian Academy of Neurology (01-07-2022)
    “…Objectives: Parkinson's disease (PD) patients have suffered during the coronavirus disease 2019 pandemic, with worsening of both motor and nonmotor symptoms…”
    Get full text
    Journal Article
  5. 5

    Mitochondrial Deficits Accompany Cognitive Decline Following Single Bilateral Intracerebroventricular Streptozotocin by Paidi, Ramesh K, Nthenge-Ngumbau, Dominic N, Singh, Raghavendra, Kankanala, Thulasi, Mehta, Hina, Mohanakumar, Kochupurackal P

    Published in Current Alzheimer research (01-09-2015)
    “…Bilateral intracerebroventricular (ICV) administration of streptozotocin (STZ) causes Alzheimer's disease (AD)-type neurodegeneration in rats. The model is…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Attention deficit-hyperactivity disorder suffers from mitochondrial dysfunction by Verma, Poonam, Singh, Alpana, Nthenge-Ngumbau, Dominic Ngima, Rajamma, Usha, Sinha, Swagata, Mukhopadhyay, Kanchan, Mohanakumar, Kochupurackal P

    Published in BBA clinical (01-12-2016)
    “…Pathophysiology of attention-deficit hyperactivity disorder (ADHD) is not known, and therefore the present study investigated mitochondrial defects, if any in…”
    Get full text
    Journal Article
  9. 9

    Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats by Tripathy, Debasmita, Haobam, Reena, Nair, Ranju, Mohanakumar, Kochupurackal P

    Published in PloS one (12-09-2013)
    “…We report here protection against rotenone-induced behavioural dysfunction, striatal dopamine depletion and nigral neuronal loss, following intra-striatal…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease by Saravanan, Karuppagounder S., Sindhu, Kizhakke M., Mohanakumar, Kochupurackal P.

    Published in Brain research (12-07-2005)
    “…We examined in Sprague–Dawley rats whether intranigral administration of complex-I inhibitor, rotenone, produces biochemical lesions in the striatum similar to…”
    Get full text
    Journal Article
  12. 12

    Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats by Haobam, Reena, Tripathy, Debasmita, Kaidery, Navneet A, Mohanakumar, Kochupurackal P

    Published in Rejuvenation research (01-04-2015)
    “…6-Hydroxydopamine (6-OHDA)- and 1-methyl-4-phenylpyridinium (MPP(+))-induced hemi-parkinsonism was investigated in relation to the severity of the disorder in…”
    Get more information
    Journal Article
  13. 13

    Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: A comparative study in two mouse strains by Haobam, Reena, Sindhu, Kizhakke M., Chandra, Goutam, Mohanakumar, Kochupurackal P.

    Published in Behavioural brain research (08-09-2005)
    “…Parkinson's disease (PD) is a common neurodegenerative disease that exhibits motor dysfunctions, such as tremor, akinesia and rigidity. In the present study,…”
    Get full text
    Journal Article
  14. 14

    Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson’s Disease? by Nthenge-Ngumbau, Dominic Ngima, Mohanakumar, Kochupurackal P.

    Published in Molecular neurobiology (2018)
    “…Parkinson’s disease (PD) has no known cure; available therapies are only capable of offering temporary, symptomatic relief to the patients. Varied therapeutic…”
    Get full text
    Journal Article
  15. 15

    Efficacy of defensins as neutralizing agents against the deadly SARS-CoV-2 by Deepthi, Varughese, Mohanakumar, Kochupurackal P, Rajamma, Usha

    “…SARS-CoV-2 infection causes asymptomatic to severe human respiratory diseases. Vaccinations are effective only to a certain extent, and the disease recurs with…”
    Get full text
    Journal Article
  16. 16

    The light at the end of the tunnel gets vivid for spinal muscular atrophy: An Editorial Highlight for "Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy" on page 650 by Dutta, Debashis, Chandra, Goutam, Mohanakumar, Kochupurackal P

    Published in Journal of neurochemistry (01-06-2020)
    “…Kessler et al. in this current issue have attempted to discern biomarker(s) for spinal muscular atrophy (SMA) by assessing alterations in cerebrospinal fluid…”
    Get full text
    Journal Article
  17. 17

    Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice by Singh, Alpana, Verma, Poonam, Balaji, Gillela, Samantaray, Supriti, Mohanakumar, Kochupurackal P.

    Published in Neurochemistry international (01-10-2016)
    “…Parkinson’s disease (PD), the most common progressive neurodegenerative movement disorder, results from loss of dopaminergic neurons of substantia nigra pars…”
    Get full text
    Journal Article
  18. 18

    Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice by Naskar, Amit, Prabhakar, Visakh, Singh, Raghavendra, Dutta, Debashis, Mohanakumar, Kochupurackal P.

    Published in Journal of pineal research (01-04-2015)
    “…L‐3,4‐dihydroxyphenylalanine (L‐DOPA) reduces symptoms of Parkinson's disease (PD), but suffers from serious side effects on long‐term use. Melatonin…”
    Get full text
    Journal Article
  19. 19

    Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits by Dutta, Debashis, Mohanakumar, Kochupurackal P.

    Published in Neurochemistry international (01-10-2015)
    “…The major neurodegenerative movement disorder Parkinson's disease (PD) is characterized by rest-tremor, akinesia, rigidity and inability to initiate movements…”
    Get full text
    Journal Article
  20. 20

    Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders by Jaiswal, Preeti, Mohanakumar, Kochupurackal P, Rajamma, Usha

    Published in Neuroscience and biobehavioral reviews (01-08-2015)
    “…Serotonergic system has long been implicated in the aetiology of autism spectrum disorders (ASD), since platelet hyperserotonemia is consistently observed in a…”
    Get full text
    Journal Article